Institut Pasteur de Lille
The Drug Discovery Center U1177 INSERM-Institut Pasteur de Lille-University of Lille (www.deprezlab.fr) is dedicated the design, optimisation and characterization of compounds for therapeutic applications. The candidate’s role will be to design, develop and use relevant in vitro assays to characterize ERAP inhibitors and understand the biological functions of these proteins, and participate in the analysis of in vivo experiments.
Pierre Louis Institute of Epidemiology and Public Health, Sorbonne, Paris
Post-doctoral position in Pharmacoepidemiology for 3 years for an ERC-funded project in Sorbonne Université / Inserm (Paris, France) on the benefit-risk balance of advanced therapies in inflammatory bowel disease.
UMR Right, Besançon
The candidate will investigate how CD4 help (cytokines, chemokines, costimulation signaling, DC licensing) supports effective differentiation of CD8 T cells during antigen persistence. These findings will be critical for the design of new combination therapies with PD-1 blockade to achieve long-term benefit.
INCIT, Inserm, Nantes
NCIT (Inserm, Nantes) is opening a tenure-track chair to recruit an emerging scientific leader in adoptive T cell therapy. We seek a highly skilled researcher in T cell engineering, receptor design, and gene editing, eager to drive the next generation of multi-specific ACT strategies in different pathological contexts. You'll thrive in a dynamic environment with advanced platforms and strong clinical ties.
Laboratoire de chimie bactérienne, Marseille
The successful candidate will lead a project to establish a model of spatial differentiation in the predatory bacterium Myxococcus xanthus, combining quantitative imaging experiments to detect intercellular signals with mathematical models.
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne
A post-doctoral position (30 months) is currently available for a collaborative project (co-PI: Pr. Aimin XU, The University of Hong Kong, China), focusing on the role of TMEM33 in fatty liver disease. Candidates should have a keen interest in understanding metabolism, liver physiology and associated disease states. A strong backround in lipid biology and mouse experimentation is required.
Universite de Montpellier
Today, the CRBM develops fundamental research specialized in cell biology. This recruitment aims to complement the experimental approach of the “Cytoplasmic Control of Genome Stability” research team, where the Saccharomyces cerevisiae and human cell study models are already well established, by now consolidating a new study model, namely the tardigrade Hypsibius exemplaris.
Lyon Hepatology Institute
We are looking for a talented, dynamic and motivated investigator to develop an ambitious project in liver pathobiology on bioinformatics and biostatistics that will cover one or more of the following topics: virology, metabolism, oncology, immunology and inflammation, liver regeneration, organ preservation. The position will be funded by a program supported by the French National Research Agency call “Chair Professeur Junior” and by the Hepatology Institute.
This is a facilitated path to tenure to obtain a position as a full Professor at the Claude Bernard Lyon 1 University.
Lyon Hepatology Institute
We are looking for a talented, dynamic and motivated investigator to develop an ambitious project in liver pathobiology on one of the following topics: virology, metabolism, oncology, immunology and inflammation, liver regeneration, organ preservation. The position will be funded by the Hepatology Institute.
Cancer Research Center (CRCT), Toulouse
The specific aim of the project is to define the molecular mechanisms of tumor cell resistance to cytotoxic T lymphocyte (CTL) attack at the immunological synapse and to dissect their cell death pathways.